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Abstract 
 
Abstract | Crohn’s disease and ulcerative colitis, collectively known as IBD, are chronic 
inflammatory disorders of the gastrointestinal tract. Although the aetiopathogenesis of IBD is 
largely unknown, it is widely thought that diet has a crucial role in the development and 
progression of IBD. Indeed, epidemiological and genetic association studies have identified a 
number of promising dietary and genetic risk factors for IBD. These preliminary studies have led 
to major interest in investigating the complex interaction between diet, host genetics, the gut 
microbiota and immune function in the pathogenesis of IBD. In this review, we discuss the 
recent epidemiological, gene–environment interaction, microbiome and animal studies that have 
explored the relationship between diet and the risk of IBD. In addition, we highlight the 
limitations of these prior studies, in part by explaining their contradictory findings, and review 
future directions. 
  
Introduction 
 
Crohn’s disease and ulcerative colitis, collectively known as IBD, are chronic inflammatory 
disorders of the gastrointestinal tract that have an increasing incidence1 and affect over one 
million individuals in the US and 2.5 million individuals in Europe2,3, resulting in substantial 
morbidity4, health- care expenses and loss of productivity in the work environment5,6. Although 
the pathophysiology of IBD is largely unknown, it is thought to be related to an inappropriate 
immune response to commensal bacteria in genetically susceptible hosts (Fig. 1). A role for 
genetic risk factors in the development of IBD has been highlighted by the identification of >200 
susceptibility loci in genome- wide association studies (GWAS)7,8. In addition to the genetic 
contribution to IBD pathophysiology, environmental factors also seem to substantially contribute 
to both the development and progression of IBD. For instance, twin studies have demonstrated 
a <50% concordance in the development of Crohn’s disease and ulcerative colitis9,10. In 
addition, epidemiological studies have confirmed the rapid increase in the incidence of IBD in 
the US and developing countries that have witnessed a dramatic Westernization of lifestyle, with 
the worldwide prevalence of the disease having surpassed 0.3% at the turn of the twenty- first 
century1,11. Moreover, studies have shown that the incidence of IBD in immigrants to developed 
countries exceeds that of individuals from their country of origin12–15.  
 
Among environmental factors, diet is widely thought to have a pivotal role in the development of 
IBD. Although the exact pathophysiological mechanisms remain unknown, several plausible 
explanations have been proposed (Fig. 2). First, diet has a key role in defining the composition 
of the human gut microbiota and, consequently, that of microbial metabolites16. Second, food 
and nutrients associated with a Western diet — characterized by high intakes of red meat, 
sugary desserts, high- fat foods and refined grains — have been linked to increased mucosal 
inflammation as measured by stool calprotectin levels in human subjects17. Last, animal studies 
have demonstrated that dietary composition regulates mucosal barrier function, a crucial factor 
in the pathogenesis of IBD18,19. Despite these data, human observational studies investigating 
the role of diet in IBD have yielded contradictory and inconclusive results.  
 
In this Review, we discuss the available data on the role of diet in the pathogenesis of IBD with 
a focus on epidemiological, gene–environment interaction, intervention, gut microbiome and 
animal studies. We also highlight the limitations of prior studies, particularly epidemiological and 
gene–environment studies, and review future directions that build upon these preliminary 
studies  
 
 
Intervention studies 
There has been a resurgence of interest in the potential of dietary intervention for the treatment 
of IBD. Although a comprehensive discussion of prior dietary intervention studies is beyond the 
scope of this review and has been previously published20, the early success of these studies 
further supports a role for diet in the pathogenesis of IBD. For example, several studies have 
demonstrated that exclusive enteral nutrition (EEN), which involves the administration of a liquid 
diet formula for a defined period of time, improves both clinical symptoms and intestinal 
inflammation in patients with Crohn’s disease; one randomized controlled trial demonstrated 
that a short- term EEN was superior to corticosteroids in promoting mucosal healing in 
paediatric patients with Crohn’s disease21,22. Nevertheless, similar studies in adults, where 
compliance to such a restrictive diet might be challenging, have not been as promising22. Last, 
several uncontrolled human intervention studies have also reported promising results for other 
diets in the treatment of IBD, including the specific carbohydrate diet, the low- fermentable 
oligosaccharide, disaccharide, monosaccharide and polyol (FODMAP) diet and the Palaeolithic 
diet23. Although large, well- designed, randomized studies in humans are needed to fully 
examine the therapeutic effects of these diets in IBD, these early results suggest a role for diet 
in the pathogenesis of IBD and support the need for further investigation in this area. 
  
Epidemiologic Studies 
 
A limited number of prior studies have examined the association between specific dietary 
factors and risk of IBD24–26. Unfortunately, many of these studies have a number of drawbacks. 
Specifically, most prior studies were retrospective case–control analyses and are therefore 
subject to numerous limitations including recall and selection biases. Recall bias of diet before 
the onset of IBD symptoms is particularly problematic. For example, if individuals are recruited 
after an extended period following diagnosis, they might have considerably changed their diet or 
preferentially recall consumption of specific foods that exacerbate their symptoms. Similarly, 
recall of diet within a very brief interval after diagnosis is subject to concerns about reverse 
causation, whereby symptoms that immediately precede the formal diagnosis might alter dietary 
intake. In addition, the majority of previous studies collected dietary data at a single time point 
and were therefore unable to account for variations in dietary intake over time. There have also 
been very few studies that have rigorously validated dietary assessments within their study 
populations. Finally, because of the low absolute incidence of IBD in the general population, 
most prior cohort studies have been limited by sample size. Taken together, these limitations 
might contribute to the inconsistent associations between dietary factors and the risk of IBD that 
is generally seen in the scientific literature.  
 
To address these limitations, several large prospective cohort studies over the past 10 years 
have attempted to better characterize the link between diet and risk of IBD by leveraging 
validated and updated dietary data collected during long- term follow- up (Table 1). The majority 
of these studies used the semi- quantitative food frequency questionnaire (SFFQ) to estimate 
long- term dietary intake. The SFFQ is a method of assessing food and nutrient intake over a 
specified period of time by obtaining data on the frequency — and in some cases portion sizes 
— of food and beverage consumption27. The SFFQ has several advantages over other forms of 
dietary assessment (such as 24-hour recall or dietary records) in that it focuses on patterns of 
dietary intake over longer periods of time and therefore avoids biases that could be introduced 
through the episodic or occasional consumption of specific foods and beverages. In addition, 
SFFQs are relatively easy to complete by participants, therefore providing an ideal method to 
conduct large- scale epidemiological studies of diet in chronic diseases. Last, the SFFQ has 
been extensively validated against diet records (Box 1), allowing for the use of statistical 
methods to account for measurement errors. By contrast, the SFFQ is limited by its use in 
specific populations with well- characterized patterns of dietary consumption (for example, 
Western societies) and is subject to over- reporting of consumption of healthy foods as a 
consequence of social desirability bias.  
 
Dietary studies in the Nurses’ Health Study. The Nurses’ Health Study (NHS) is a 
prospective cohort study that began in 1976 when 121,701 female registered nurses aged 30–
55 years completed a mailed health questionnaire28. Similar baseline questionnaires were 
returned in 1989 from a parallel cohort of 116,686 female nurses aged 25–42 years that were 
enrolled in NHSII. Questionnaires have been mailed to members of both cohorts every 2 years, 
starting in 1976 for NHS and in 1989 for NHSII, to obtain updated information on diet, lifestyle 
and medical diagnoses, with a follow- up rate of >90% until 2012 for the NHS and until 2013 for 
the NHSII. Dietary data are collected every 4 years in these cohorts through a 161-item SFFQ.  
 
Early work from the NHS and NHSII showed a low risk of Crohn’s disease among individuals 
who consume high amounts of fibre, particularly fibre from vegetables and fruits29 (Table 1). By 
contrast, a high omega-3 (n-3) to n-6 polyunsaturated fatty acid (PUFA) ratio was associated 
with a low risk of ulcerative colitis, whereas a high intake of red meat was associated with an 
increased risk of ulcerative colitis30,31 (Table 1). Owing to the increasingly recognized role of 
specific nutrients and electrolytes such as haem, potassium and zinc in regulating the intestinal 
barrier and immune function32–39, studies from the past 5 years have focused on examining the 
relationship between quantity of nutrient consumption and risk of IBD. Preliminary data from 
these cohorts have shown an inverse association between dietary zinc and potassium intake 
and risk of Crohn’s disease, whereas dietary sodium, haem and iron intake were not associated 
with IBD risk31,40,41 (Table 1). 
 
Dietary studies in the European Prospective Investigation in Cancer study. The European 
Prospective Investigation in Cancer (EPIC) study, which investigated the link between dietary 
intake and the risk of common malignant diseases in the general population, comprised 519,978 
men and women recruited from 23 centres in 10 European countries42. The EPIC–IBD study is a 
subcohort of the EPIC study that involved a total of 401,326 initially healthy men and women 
aged 20–80 years who did not have Crohn’s disease or ulcerative colitis and who were recruited 
from 12 centres in 8 European countries between 1991 and 1998. EPIC–IBD participants 
provided information on age, gender and lifestyle factors (such as smoking, physical activity 
levels and dietary information) through the self- completion of questionnaires at baseline. The 
follow- up rate until 2010 in EPIC–IBD was >98%. Dietary assessment in EPIC–IBD was 
conducted at baseline when participants reported dietary intake using country- specific validated 
questionnaires42. In most centres, a self- administered SFFQ was used to assess dietary intake 
(with 88–266 food- related questions) over the previous 12 months. Interviewer- administered 
diet questionnaires were used in Greece and Spain and in Ragusa, Italy. In the EPIC study, 
almost 10% of the cohort (~37,000 individuals) was assessed using a single highly 
standardized, 24-hour recall of actual food consumption to account for any between- cohort 
differences that might exist in systematic exposure measurement error as well as for within-
cohort attenuation biases in relative risk estimates. The energy-adjusted intakes were used to 
estimate correlations between SFFQ and 24-hour recall, and the mean intake levels estimated 
from 24-hour recall were used to account for within-cohort and between-cohort variations, 
respectively43.  
 
Before the establishment of the EPIC–IBD cohort, one study from EPIC that consisted of 
260,686 participants from 10 centres across 5 countries investigated the associations between 
intake of a total of 18 nutrients, vitamins and minerals and the risk of ulcerative colitis44. No 
associations were detected, with the exception of a weak positive association between 
increased total PUFA intake as a percentage of total energy intake and increased risk of 
developing ulcerative colitis. A similar broad analysis has yet to be published for Crohn’s 
disease in this particular cohort. However, following these initial results, a subsequent study 
from the EPIC–IBD study further investigated the associations between intake of PUFAs and 
ulcerative colitis45. On the basis of findings by other groups that n-6 PUFAs are metabolized to 
pro- inflammatory lipid mediators46,47, this study hypothesized that individuals with the highest 
dietary intakes of n-6 PUFAs would have an increased risk of developing ulcerative colitis. 
Indeed, the highest quintile for dietary intakes of the n-6 PUFA linoleic acid, as measured by the 
SFFQ, was associated with an increased risk of developing ulcerative colitis (OR 2.49, 95% CI 
1.23–5.07)45 (Table 1). Conversely, the same study found that participants with the highest 
quintile for dietary intakes of docosahexaenoic acid (DHA), an n-3 PUFA that is metabolized to 
anti- inflammatory lipid mediators, had a decreased risk of developing ulcerative colitis (OR 
0.23, 95% CI 0.06–0.97). Although similar findings for DHA intake and risk of Crohn’s disease 
have been reported in the EPIC–IBD study48, no associations between n-6 PUFA intake and 
Crohn’s disease have been found in EPIC–IBD to date48 (Table 1).  
 
By contrast, investigations into the role of monosaccharide, disaccharide and starch intake in 
developing ulcerative colitis or Crohn’s disease in EPIC–IBD have not demonstrated any 
consistent associations49 (Table 1). Interestingly, however, EPIC–IBD study participants in the 
highest quintile for diets rich in sugar and soft drinks had an increased risk of developing 
ulcerative colitis (incidence rate ratio (IRR) 1.68, 95% CI 1.00–2.82)50 (Table 1). This finding 
was mainly attributed to those individuals with a dietary pattern of high intake of sugar and soft 
drinks who had intakes of vegetables, legumes and fruit that were below that of the median 
population (OR 2.80, 95% CI 1.54–5.09)50. High consumption of milk has been shown to be 
associated with decreased risk of developing Crohn’s disease but not ulcerative colitis, 
independent of dietary calcium intake51. However, the association did not show a dose–
response relationship, and there was no association between total intake of dairy products, 
yogurt or cheese with either ulcerative colitis or Crohn’s disease. Finally, investigations into 
alcohol intake and the risk of developing ulcerative colitis or Crohn’s disease in EPIC–IBD have 
not reported any statistically significant associations52, despite speculation that isoflavones in 
alcoholic beverages, which accumulate during the fermentation process53, might have 
antioxidant and immune modulatory effects on the basis of findings from preclinical studies54.  
 
Limitations of prospective cohort studies and future directions. Despite offering unique 
opportunities to study dietary factors in relation to IBD incidence, both the EPIC and NHS 
studies are limited by the underrepresentation of individuals with an early onset of IBD (age <40 
years). This drawback limits the generalizability of the findings of these studies, particularly 
regarding individuals who were diagnosed with IBD before the age of 40 years. Although dietary 
data derived from these cohorts have been extensively validated, the correlation between SFFQ 
and dietary records, considered to be the gold standard, is modest for many foods and 
nutrients, which in turn can be a source of considerable measurement errors. In addition, 
despite being the largest cohort studies to date that have examined the link between diet and 
risk of IBD, the number of incident cases of IBD in these studies is limited, precluding the 
identification of more modest associations.  
 
Thus, there continues to be an unmet need for a comprehensive, prospective examination of the 
association between diet and risk of IBD. Such an effort could perhaps be achieved through the 
establishment of a large international consortium and could be used to achieve a number of 
important aims. First, such an effort could improve our understanding of the associations 
between dietary patterns and risk of IBD across cohort studies comprised of different 
populations with a wide distribution of participant characteristics. Second, it could be used to 
examine the presence of dose–response relationships across a wide exposure range. Third, it 
could serve to generate summary estimates that have greater precision than the individual 
studies owing to the larger sample size, therefore allowing examination of the population- 
attributable risk of dietary factors in IBD. Finally, such a collaborative effort could allow for 
examinations of whether associations differ within specific population subgroups. These 
analyses are particularly important, as they might identify subgroups of the population that might 
benefit the most from specific lifestyle interventions. In addition, given that IBD is a 
heterogeneous disease, the evaluation of whether associations vary by disease subtype might 
lead to a better understanding of the aetiology of IBD.    
 
Animal studies 
Dietary factors are known to induce insulin resistance, influence the balance of fatty acids that 
elicit or reduce inflammation of the gut epithelium, modify intestinal permeability and contribute 
to sulfur production, all of which in turn alter the gut microbiota composition by promoting the 
growth of sulfate- reducing bacteria55,56. Animal studies have shown that a Western diet 
increases the susceptibility of mice to dextran sodium sulfate (DSS)-induced colitis and 
increases the infiltration of macrophages compared with a Mediterranean diet, which is 
characterized by a high intake of fruits, vegetables, whole- grain foods, poultry and fish57. In 
addition, a Western diet in mice alters host intestinal barrier function by increasing the 
colonization of adherent- invasive Escherichia coli18. Similarly, in mice, a high- fat diet was 
shown to disrupt gut barrier function by modifying the composition of luminal bile salts19. 
Although dietary fibre has been shown to exert its anti- inflammatory effect by modulating the 
composition of the gut microbiota, increasing colonic fermentation and promoting the production 
of short- chain fatty acids, studies in mouse models of colitis have also shown that fibre might 
have a direct immunomodulatory effect through inhibition of pro- inflammatory cytokine 
production in peripheral blood mononuclear cells58. Additionally, in a model of Citrobacter 
rodentium induced acute colitis, a fibre- rich diet reduced inflammation by modifying the host 
microbiota to increase production of short- chain fatty acids and by altering host immune 
mechanisms of bacterial recognition and response to promote host health. In contrast to fibre, 
dietary red meat exacerbates DSS-induced colitis in mice59.  
 
Although the exact mechanism underlying this observation is unclear, one potential explanation 
is that animal proteins increase luminal levels of sphingosine-1-phosphate, a sphingolipid 
involved in cell signalling that has been shown to increase inflammation in mice models of 
colitis60–62. Over the past 5 years, interest in the role of dietary sodium in regulating the immune 
response has been growing. Several animal studies have shown a role for dietary sodium intake 
in the development and progression of autoimmune disorders through IL-23–IL-23 receptor (IL-
23R)-mediated activation of pathogenic pro- inflammatory T helper 17 (TH17) cells, which have 
a critical role in the development of IBD34–36. In addition to enhancing the induction of pro- 
inflammatory TH17 cells, sodium also seems to suppress immune tolerance by inhibiting the 
immunosuppressive functions of forkhead box protein P3 (FOXP3)+ regulatory T (Treg) cells63. 
Sodium might also lead to activation of proinflammatory macrophages64. In contrast to sodium, 
a study published in 2016 demonstrated the profound suppressive effect of potassium released 
into the extracellular fluid as a result of necrosis in human tumours on T cell effector function33. 
In turn, the study also demonstrated that augmentation of potassium efflux in tumour- specific T 
cells improved their effector function and promoted tumour clearance. Together, these findings 
demonstrate the critical role of sodium and potassium in regulating the TH17 cell:Treg cell 
balance (Fig. 2).  
 
 
 
Gene-Environment Studies of Diet in IBD 
 
Studies investigating the interaction between environmental components and genetic variants in 
functionally annotated genes have been increasingly used to help infer causal associations65 
and provide insight into potential biological pathways through which an environmental factor 
such as diet might contribute to the aetiopathogenesis of chronic diseases, including IBD. 
Genetic loci associated with IBD risk can be broadly categorized into those involving 
abnormalities in the innate and/or adaptive immune response and mucosal barrier function66. 
Experimental data also suggest that many of these pathways are influenced by dietary factors67. 
Thus, it is biologically plausible that specific dietary components have differential effects on the 
incidence of IBD according to the genetic background. Data on the influence of gene–
environment interaction on IBD risk are sparse. This paucity is largely due to the limited 
availability of well- characterized cohorts with detailed, updated and validated data on dietary 
and lifestyle factors with simultaneous annotation of genetic variants. In addition, owing to the 
low incidence of IBD in the general population, many cohort studies have a limited number of 
participants, precluding the possibility of assessing gene–environment interactions. 
Nevertheless, the investigation of gene–environment interaction is an area of great unmet need, 
as results from such studies will not only shed light on the complex interaction between diet, 
genetic susceptibility and immune function but could also help to inform dietary 
recommendations for individuals at a high risk of IBD or those with established disease. 
Preliminary analyses of gene–environment interaction in studies incorporating dietary factors in 
IBD have been promising40,68–70 (Table 2). An analysis from the NHS and NHSII, which included 
169 individuals with Crohn’s disease and 202 individuals with ulcerative colitis matched to 740 
control participants, examined the interaction between total dietary intake of iron and haem iron 
and genetic variants associated with risk of IBD31. This study demonstrated an interaction 
between iron and haem iron intake and the ulcerative colitis susceptibility locus rs1801274, a 
coding variant in the FCGR2A (which encodes the low affinity immunoglobulin- γ Fc region 
receptor IIa) gene. Specifically, among women with the GG genotype, increasing haem iron 
intake was associated with a substantially lower risk of ulcerative colitis (OR 0.11, 95% CI 0.03–
0.37 for each 1 g increase in haem iron intake) (Table 2). By contrast, among women with the 
TT genotype, increasing haem iron intake was associated with an almost threefold higher risk of 
ulcerative colitis (OR 2.76, 95% CI 1.02–7.48). Owing to the crucial role of FCGR2A in 
regulating humoral response to infection71 and the known importance of the rs1801274 variant 
in altering the binding capacity of the encoded protein product to C- reactive protein (CRP) and 
immunoglobulin G2 (IgG2)72–74, these data provide evidence for an intriguing interaction 
between dietary haem intake and immune function in the development of ulcerative colitis. 
Similarly, in a nested case–control study of 202 individuals with ulcerative colitis and 169 
individuals with Crohn’s disease in the NHS and NHSII cohorts matched to 740 control 
participants on the basis of age, menopausal status, month of blood collection and fasting 
status, an interaction between dietary potassium intake and genetic variants in the IL-23 
pathway that have been previously associated with risk of IBD in GWAS was identified40,66. 
Specifically, the rs7657746 variant of IL21 (which encodes IL-21) seemed to modify the 
association between potassium intake and risk of IBD (Table 2). Each 200 mg increase in 
dietary potassium intake was inversely associated with risk of ulcerative colitis (OR 0.90, 95% 
CI 0.82–0.98) among participants with the AA genotype, but not among those with the AG or 
GG genotypes. Similar findings were observed in patients with Crohn’s disease in this study. As 
IL-21 has a key role in the development of TH17 cells through signal transducer and activator of 
transcription 3 (STAT3), a transcription factor required for the differentiation of TH17 cells in 
vivo, the findings from gene–environment interaction studies suggest a potential mechanism for 
the observed association75. IL-21 and IL-23 induce expression of the nuclear receptor RORγ 
(also known as RORC), which, in synergy with STAT3, promotes IL-17 expression in CD4+ T 
cells, leading to the activation of TH17 cells75. 
  
In addition, IL-21 inhibits the transforming growth factor-β (TGFβ)-dependent generation of 
FOXP3+ Treg cells and induces TH17 cell activation76. Interestingly, in this study, the gene–
environment interaction finding was further supported by in vitro studies demonstrating that 
potassium induces FOXP3 expression in naive and memory T cells and in pro-inflammatory TH 
17 cells. This effect was present even in the presence of pro-inflammatory cytokine, suggesting 
that potassium suppresses inflammation in a pro- inflammatory milieu. Last, data from the NHS 
and NHSII have also demonstrated that two variants in CYP4F3, which encodes the cytochrome 
P450 4F3 enzyme (CYP4F3) involved in PUFA metabolism, might modify the association 
between n-3 and n-6 PUFA intake and risk of ulcerative colitis69 (Table 2). Specifically, the 
association between n-3:n-6 PUFA intake ratio and ulcerative colitis was modified by the 
rs4646904 single nucleotide polymorphism (SNP) in CYP4F3 (Pinteraction = 0.049). A high 
(greater than or equal to the median) n-3:n-6 PUFA intake ratio was associated with a lower risk 
of ulcerative colitis among women with the GG or AG genotypes (OR 0.57, 95% CI 0.32–0.99), 
but not among those with the AA genotype (OR 0.95, 95% CI 0.47–1.93). Indeed, similar 
findings were previously reported in a case– control study of children with newly diagnosed 
Crohn’s disease70, suggesting that the interaction is robust. 
 
Limitations of prior gene–environment studies and future directions. Despite the early 
promising results from gene–environment studies, it is important to acknowledge the limitations 
of these data. First, most of these studies had a limited sample size and were therefore not 
adequately powered to broadly assess (that is, on a genome- wide level) the presence of gene–
environment interactions. Second, despite the presence of stringent P value thresholds in these 
preliminary studies, as demonstrated in previous validation studies, even robust findings might 
still represent spurious associations, further emphasizing the need for validation studies 
regarding gene–environment interactions77,78. Third, owing to the limited sample size and the 
adjustment of most of these studies for multiple variables, these preliminary studies might have 
been prone to type II error. Last, although gene–environment interaction analyses might 
elucidate potential biological mechanisms underpinning the link between diet and IBD, statistical 
interaction does not imply biological modification; thus, further mechanistic studies are needed 
to fully characterize the results of these studies. Despite these limitations, preliminary findings 
highlight the need for larger- scale analyses of the influence of the interaction between diet and 
genetics on risk of IBD, reinforcing the need for large international consortia composed of well- 
characterized cohort studies with simultaneous assessment of genetic and dietary data.    
 
Gut microbiota studies  
Diet is widely linked to the composition of the human gut microbiome and microbial 
metabolites79. Although much of the microbial diversity seen in the adult gut might be attained 
by the age of 4 years, the adult microbiome remains susceptible to the influence of diet80. 
Indeed, dietary patterns have been proposed to explain greater than half of the variation in the 
adult intestinal microbiome80. Accordingly, the gut microbiome has a crucial role in the 
pathogenesis of IBD, as evidenced by observations that infusion of intestinal luminal contents 
into excluded ileum triggers postoperative recurrence in patients with Crohn’s disease81. 
Furthermore, in mouse models of colitis, microbial colonization is required for the development 
of active inflammation82,83. Thus, diet, through its modulatory effect on the gut microbiota, might 
modify the risk of developing IBD (Fig. 2).  
 
Patients with established IBD have dysbiosis of the gut microbiome, which is characterized by 
reduced bacterial diversity, enrichment of bacteria of the family Enterobacteriaceae and reduced 
abundance of bacteria of the phylum Firmicutes and the genus Bacteroides80,84–86 (Fig. 2). 
Interestingly, similar patterns of bacterial enrichment have been reported in observational 
studies of healthy volunteers fed a high- fat, low- fibre diet, suggesting that prior epidemiological 
findings demonstrating an inverse association between fibre intake and risk of Crohn’s disease 
are in part explained by diet-mediated alteration of the gut microbiota in genetically susceptible 
individuals87,88.  
 
The majority of prior studies investigating the interaction between diet, the microbiome and 
intestinal inflammation have been conducted in animal models of colitis. In mice, dietary haem 
iron was shown to directly injure the colonic surface epithelium through the generation of 
cytotoxic and oxidative stress89,90. Moreover, increased dietary haem iron intake has also been 
associated with marked changes in the composition of the gut microbiota, with an increased 
ratio of Gram- negative:Gram- positive bacteria in mice91. This effect was primarily driven by the 
increased abundance of Gram- negative species, including those belonging to the genera 
Bacteroides and Akkermansia, leading to a marked increase in lipopolysaccharide production91. 
In a 2017 study, Akkermansia muciniphila was shown in mice to be a pathobiont, promoting 
colitis in genetically susceptible hosts92. Interestingly, alteration in the function of the gut 
mucosal barrier related to dietary intake of haem iron seems to be dependent on the presence 
of sulfideproducing and mucin- degrading bacteria (for example, Akkermansia spp.)89. By 
contrast, in a mouse model of spontaneous ileitis, depletion of luminal iron altered gut microbial 
composition to promote inflammation93. Finally, a high- fat diet has been linked to changes in 
phospholipid profile and bacteria taxa in the gut, highlighting the complex interactions between 
the host and the gut microbiome in response to high fat intake94,95. More specifically, high intake 
of saturated fat altered the gut microbiome, characterized by an increase in the sulfite- reducing 
pathobiont Bilophila wadsworthia, and induced colonic inflammation in Il10-knockout mice96. 
This data provided a potential mechanism by which diets high in saturated fat might increase 
the risk of IBD in a susceptible host.  
 
Human observational studies examining the interaction between diet, the microbiome and IBD 
are scarce. Among these studies is the ongoing multinational Genetics, Environment and 
Microbiome study that aims to identify factors that increase the risk of IBD97,98. This study is 
examining several environmental exposures, such as being breastfed and the composition of 
the microbiome, in a cohort of patients at high risk of IBD. Interestingly, preliminary data from 
this study have not shown a correlation between intestinal permeability — a key pathogenic 
pathway in IBD that is known to be influenced by diet67 — and the gut microbiota98. Specific 
patterns of association have been reported in a large Dutch cohort, in which total carbohydrate 
intake and features of a Western diet, including high caloric intake and consumption of sugar- 
sweetened beverages, were negatively associated with gut microbiome diversity99. By contrast, 
features of a Mediterranean diet, such as consumption of fruits, vegetables and red wine, were 
associated with increased diversity of the gut microbiome. Red wine consumption was also 
associated with the increased abundance of Faecalibacterium prausnitzii, which has been 
proposed to have anti- inflammatory properties in patients with IBD100.  
 
Several studies have examined the correlation between host genetics and the gut microbiome in 
healthy individuals and patients with IBD101–103. Generally, these studies have established a 
potential association between several genetic variants, including IBD- specific risk variants, and 
the gut microbiome. However, perhaps the most intriguing finding has been the observation that 
gene–diet interaction could in part regulate the composition of the human gut microbiome. Using 
metagenomic data from >1,500 healthy individuals, it was found that the abundance of bacteria 
of the genus Bifidobacterium was regulated by a functional variant within the LCT gene, which 
encodes lactase, the enzyme responsible for the breakdown of lactose104. Interestingly, this 
association was further modified by dairy intake. These studies further illustrate the interaction 
between diet, host genetics and the gut microbiome in human health and diseases of the 
gastrointestinal tract and highlight the complex relationship between these factors in studying 
IBD pathogenesis (Fig. 3).  
 
Conclusions  
There is a growing body of evidence suggesting a role for diet in the development of IBD, 
particularly among genetically susceptible individuals. In addition, data from animal studies 
suggest that dietary modification alters the risk of IBD. Nevertheless, there continues to be a 
substantial need for a comprehensive evaluation of the role of diet in the aetiopathogenesis of 
IBD. Such studies will be challenging because of the complex nature of the relationship between 
diet, genetics, the microbiome and disease activity (Fig. 3). Several large international 
collaborations are currently in the planning stages and hope to provide an in- depth prospective 
examination of the role of specific diets in IBD and overcome many of the shortcomings of prior 
studies. The successful execution of these studies will represent a critical first step in advancing 
our understanding of the role of diet in the pathogenesis of IBD.  
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